124 related articles for article (PubMed ID: 32407968)
21. Progression of Unresected Intraductal Papillary Mucinous Neoplasms of the Pancreas to Cancer: A Systematic Review and Meta-analysis.
Choi SH; Park SH; Kim KW; Lee JY; Lee SS
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1509-1520.e4. PubMed ID: 28342950
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic neuroendocrine tumors among patients with intraductal papillary mucinous neoplasms: real association or just a coincidence?
Gill KR; Scimeca D; Stauffer J; Krishna M; Woodward TA; Jamil LH; Wallace MB; Nguyen JH; Raimondo M
JOP; 2009 Sep; 10(5):515-7. PubMed ID: 19734627
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic juice cytology as sensitive test for detecting pancreatic malignancy in intraductal papillary mucinous neoplasm of the pancreas without mural nodule.
Kawada N; Uehara H; Nagata S; Tomita Y; Nakamura H
Pancreatology; 2016; 16(5):853-8. PubMed ID: 27459913
[TBL] [Abstract][Full Text] [Related]
24. Intraductal papillary mucinous neoplasms of the pancreas (IPMNs): epidemiology, diagnosis and future aspects.
Konstantinou F; Syrigos KN; Saif MW
JOP; 2013 Mar; 14(2):141-4. PubMed ID: 23474557
[TBL] [Abstract][Full Text] [Related]
25. Chronic Pancreatitis Finding by Endoscopic Ultrasonography in the Pancreatic Parenchyma of Intraductal Papillary Mucinous Neoplasms Is Associated with Invasive Intraductal Papillary Mucinous Carcinoma.
Takenaka M; Masuda A; Shiomi H; Yagi Y; Zen Y; Sakai A; Kobayashi T; Arisaka Y; Okabe Y; Kutsumi H; Toyama H; Fukumoto T; Ku Y; Kudo M; Azuma T
Oncology; 2017; 93 Suppl 1():61-68. PubMed ID: 29258092
[TBL] [Abstract][Full Text] [Related]
26. "High-risk stigmata" of the 2012 international consensus guidelines correlate with the malignant grade of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Aso T; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Ideno N; Osoegawa T; Takahata S; Shindo K; Ushijima Y; Aishima S; Oda Y; Ito T; Mizumoto K; Tanaka M
Pancreas; 2014 Nov; 43(8):1239-43. PubMed ID: 25036910
[TBL] [Abstract][Full Text] [Related]
27. Enucleation: A treatment alternative for branch duct intraductal papillary mucinous neoplasms.
Kaiser J; Fritz S; Klauss M; Bergmann F; Hinz U; Strobel O; Schneider L; Büchler MW; Hackert T
Surgery; 2017 Mar; 161(3):602-610. PubMed ID: 27884612
[TBL] [Abstract][Full Text] [Related]
28. Does PET with CT Have Clinical Utility in the Management of Patients with Intraductal Papillary Mucinous Neoplasm?
Roch AM; Barron MR; Tann M; Sandrasegar K; Hannaford KN; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
J Am Coll Surg; 2015 Jul; 221(1):48-56. PubMed ID: 26095551
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm.
Morimatsu K; Aishima S; Yamamoto H; Hayashi A; Nakata K; Oda Y; Shindo K; Fujino M; Tanaka M; Oda Y
Hum Pathol; 2013 Sep; 44(9):1714-21. PubMed ID: 23597774
[TBL] [Abstract][Full Text] [Related]
30. Intraductal papillary mucinous neoplasms of the pancreas: clinical surveillance and malignant progression, multifocality and implications of a field-defect.
Remotti HE; Winner M; Saif MW
JOP; 2012 Mar; 13(2):135-8. PubMed ID: 22406584
[TBL] [Abstract][Full Text] [Related]
31. Intraductal Papillary Mucinous Neoplasm of the Pancreas as the Main Focus for Early Detection of Pancreatic Adenocarcinoma.
Tanaka M
Pancreas; 2018; 47(5):544-550. PubMed ID: 29702531
[TBL] [Abstract][Full Text] [Related]
32. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
[TBL] [Abstract][Full Text] [Related]
33. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.
Salvia R; Fernández-del Castillo C; Bassi C; Thayer SP; Falconi M; Mantovani W; Pederzoli P; Warshaw AL
Ann Surg; 2004 May; 239(5):678-85; discussion 685-7. PubMed ID: 15082972
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm.
Tang RS; Weinberg B; Dawson DW; Reber H; Hines OJ; Tomlinson JS; Chaudhari V; Raman S; Farrell JJ
Clin Gastroenterol Hepatol; 2008 Jul; 6(7):815-9; quiz 719. PubMed ID: 18602036
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
[No Abstract] [Full Text] [Related]
36. Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas.
Riall TS; Stager VM; Nealon WH; Townsend CM; Kuo YF; Goodwin JS; Freeman JL
J Am Coll Surg; 2007 May; 204(5):803-13; discussion 813-4. PubMed ID: 17481488
[TBL] [Abstract][Full Text] [Related]
37. Pancreatitis is frequent among patients with side-branch intraductal papillary mucinous neoplasia diagnosed by EUS.
Ringold DA; Shroff P; Sikka SK; Ylagan L; Jonnalagadda S; Early DS; Edmundowicz SA; Azar R
Gastrointest Endosc; 2009 Sep; 70(3):488-94. PubMed ID: 19555941
[TBL] [Abstract][Full Text] [Related]
38. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis.
Crippa S; Bassi C; Salvia R; Malleo G; Marchegiani G; Rebours V; Levy P; Partelli S; Suleiman SL; Banks PA; Ahmed N; Chari ST; Fernández-Del Castillo C; Falconi M
Gut; 2017 Mar; 66(3):495-506. PubMed ID: 26743012
[TBL] [Abstract][Full Text] [Related]
39. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
[TBL] [Abstract][Full Text] [Related]
40. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance.
Kang MJ; Jang JY; Lee KB; Chang YR; Kwon W; Kim SW
Ann Surg; 2014 Aug; 260(2):356-63. PubMed ID: 24378847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
